Prognostic factors for survival after salvage reirradiation of head and neck cancer

Journal of Clinical Oncology

Volumn 27, Issue 12, 2009, Pages 1983-1991

  Tanvetyanon, Tawee ^a   Padhya, Tapan ^a   McCaffrey, Judith ^a   Zhu, Weiwei ^a   Boulware, David ^a   DeConti, Ronald ^a   Trotti, Andrea ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEEDING APPARATUS; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; MULTIPLE ORGAN FAILURE; NOMOGRAM; OVERALL SURVIVAL; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SALVAGE THERAPY; SOFT TISSUE DEFECT; SURVIVAL TIME; TIME SERIES ANALYSIS; TRACHEOSTOMY; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETREATMENT; RISK FACTORS; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 65349130653     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.0691     Document Type: Article

References (25)

1. Gilbert H, Kagan AR: Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, and larynx. J Surg Oncol 6:357-380, 1974
2. Goodwin WJ Jr: Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means? Laryngoscope 110:1-18, 2000 (suppl 93)
3. Jones AS, Bin Hanafi Z, Nadapalan V, et al: Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br J Cancer 74:128-132, 1996
4. Forastiere AA, Metch B, Schuller DE, et al: Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10:1245-1251, 1992
5. Spencer SA, Harris J, Wheeler RH, et al: RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 51:1299-1304, 2001
6. Janot F, de Raucourt D, Benhamou E, et al: Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol 26:5518-5523, 2008
7. Langer CJ, Harris J, Horwitz EM, et al: Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 25: 4800-4805, 2007
8. Salama JK, Vokes EE, Chmura SJ, et al: Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 64:382-391, 2006
9. De Crevoisier R, Bourhis J, Domenge C, et al: Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 16:3556-3562, 1998
10. Hwang JM, Fu KK, Phillips TL: Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 41:1099-1111, 1998
11. Lee N, Chan K, Bekelman JE, et al: Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 68:731-740, 2007
12. Sulman EP, Schwartz DL, Le TT, et al: IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 73:399-409, 2009
13. Piccirillo JF, Spitznagel EL Jr, Vermani N, et al: Comparison of comorbidity indices for patients with head and neck cancer. Med Care 42:482-486, 2004
14. Alho OP, Hannula K, Luokkala A, et al: Differential prognostic impact of comorbidity in head and neck cancer. Head Neck 29:913-918, 2007
15. Read WL, Tierney RM, Page NC, et al: Differential prognostic impact of comorbidity. J Clin Oncol 22:3099-3103, 2004
16. Karvonen-Gutierrez CA, Ronis DL, Fowler KE, et al: Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 26:2754-2760, 2008
17. Greene FL, Page DL, Fleming ID, et al: AJCC Cancer Staging Manual (ed 6). New York, NY, Springer, 2002
18. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205-216, 2000
19. Paleri V, Wight RG: A cross-comparison of retrospective notes extraction and combined notes extraction and patient interview in the completion of a comorbidity index (ACE-27) in a cohort of United Kingdom patients with head and neck cancer. J Laryngol Otol 116:937-941, 2002
20. Paleri V, Wight RG: Applicability of the adult comorbidity evaluation - 27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: A retrospective study. J Laryngol Otol 116:200-205, 2002
21. Harrell FE Jr: Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY, Springer Verlag, 2001
22. Kim AJ, Suh JD, Sercarz JA, et al: Salvage surgery with free flap reconstruction: Factors affecting outcome after treatment of recurrent head and neck squamous carcinoma. Laryngoscope 117: 1019-1023, 2007
23. Argiris A, Brockstein BE, Haraf DJ, et al: Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res 10:1956-1962, 2004
24. Sulman EP, Schwartz DL, Le TT, et al: IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 2008 Jun 13 [Epub ahead of print]
25. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567-578, 2006